Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D

被引:9
作者
Flores-Borja, F
Kieszkievicz, J
Church, V
Francis-West, PH
Schofield, J
Rademacher, TW
Lund, T
机构
[1] UCL, Dept Immunol & Mol Pathol, London W1T 4JF, England
[2] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England
关键词
diabetes; NOD mouse; ApoA-I;
D O I
10.1016/j.biochi.2004.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycosylphosphatidylinositol phospholipase D (GPI-PLD) has been proposed to be responsible for cleaving membrane-associated glycosylphosphatidyl inositol (GPI) molecules to generate inositol phosphoglycan (IPGs), which have growth factor-mimetic properties. We have cloned the mouse liver GPI-PLD cDNA, which has a sequence that differs from that previously isolated from a mouse glucagonoma cell library. Using a highly specific and very sensitive RNase protection assay, we found that the GPI-PLD expressed in adult/post-natal brain, antrum and insulin-producing cells is identical to that isolated from liver. The expression of mouse GPI-PLD in liver shows a complex genetic regulation with a mouse strain-specific variation. In addition, GPI-PLD mRNA levels were higher in 4-week old animals compared to older animals, and the GPI-PLD mRNA levels increased in mice that developed insulin dependent type 1 diabetes spontaneously. This suggests that the expression of liver GPI-PLD in mice is highly regulated. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 50 条
  • [41] Caveolin-1 Regulation and Function in Mouse Uterus during Early Pregnancy and under Human In Vitro Decidualization
    Song, Zhuo
    Li, Bo
    Li, Mengyuan
    Luo, Jiamei
    Hong, Yuqi
    He, Yuying
    Chen, Siting
    Yang, Zhenshan
    Liang, Chen
    Yang, Zengming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [42] Loss of tolerance to beta-cell autoantigens in the NOD mouse: The role of cell-mediated immune regulation
    Bach, JF
    Herbelin, A
    Gombert, JM
    Chatenoud, L
    IMMUNE TOLERANCE: INTERNATIONAL SYMPOSIUM ON IMMUNE TOLERANCE, 1996, : 213 - 220
  • [43] Regulation of insulin gene expression by cytokines and cell-cell interactions in mouse medullary thymic epithelial cells
    Levi, D.
    Polychronakos, C.
    DIABETOLOGIA, 2009, 52 (10) : 2151 - 2158
  • [44] Genetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains
    Wang, Qian
    Grainger, Andrew T.
    Manichaikul, Ani
    Farber, Emily
    Onengut-Gumuscu, Suna
    Shi, Weibin
    BMC GENETICS, 2015, 16
  • [45] Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Funda, David P.
    Palova-Jelinkova, Lenka
    Golias, Jaroslav
    Kroulikova, Zuzana
    Fajstova, Alena
    Hudcovic, Tomas
    Spisek, Radek
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [46] UP-REGULATION OF D-MYO-INOSITOL TRANSPORT IN DIABETIC RAT GLOMERULAR CELLS
    WHITESIDE, CI
    THOMPSON, JC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03): : E301 - E306
  • [47] FAM3D: A gut secreted protein and its potential in the regulation of glucose metabolism
    Moser, Caroline
    Gossele, Katherine A.
    Balaz, Miroslav
    Balazova, Lucia
    Horvath, Carla
    Kuenzle, Patricia
    Okreglicka, Katarzyna Maria
    Li, Fengqi
    Blueher, Matthias
    Stierstorfer, Birgit
    Hess, Eva
    Lamla, Thorsten
    Hamilton, Bradford
    Klein, Holger
    Neubauer, Heike
    Wolfrum, Christian
    Wolfrum, Susanne
    PEPTIDES, 2023, 167
  • [49] LADA and T1D in Estonian population - Two different genetic risk profiles
    Kisand, Kalle
    Uibo, Raivo
    GENE, 2012, 497 (02) : 285 - 291
  • [50] Assessment of genetic and clinical factors in T2D susceptibility among patients with hypertension
    Al Hageh, Cynthia
    O'Sullivan, Siobhan
    Henschel, Andreas
    Chacar, Stephanie
    Hantouche, Mireille
    Nader, Moni
    Zalloua, Pierre A.
    ACTA DIABETOLOGICA, 2024, 61 (10) : 1259 - 1266